LTGO (LTGO) Stock Price & Analysis
LTGO (LTGO) rose 2.49% to USD 23.04 as of September 8, 2026 at 12:48 UTC, according to Nexqual real-time market data.
LTGO last closed at USD 23.04; the session ranged USD 22.02–23.55 on volume of 227,438 shares. Market capitalization is —, with a 52-week range of USD 17.22–25.93 (NMS). Source: Nexqual, September 8, 2026 at 12:48 UTC.
Key Statistics (as of September 8, 2026 at 12:48 UTC)
| Price | USD 23.04 |
|---|---|
| Change | ▲ 2.49% (up) |
| Previous Close | USD 23.04 |
| Open | USD 23.04 |
| Day Range | USD 22.02 – 23.55 |
| 52-Week Range | USD 17.22 – 25.93 |
| Volume | 227,438 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (LTGO)
Nexqual's technical model rates LTGO "BUY" based on 2 bullish and 0 bearish signals across 21 daily candles, as of September 8, 2026 at 12:48 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 65.97 (neutral) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BLSM | BlossomHill Therapeutics, Inc. | USD 22.01 | ▲ 13.57% |
| BRVE | Braveheart Bio, Inc. | USD 26.74 | ▼ 0.78% |
| COAG | Hemab Therapeutics Holdings, In | USD 44.41 | ▼ 0.65% |
| SPTX | Seaport Therapeutics, Inc. | USD 24.86 | ▼ 0.2% |
| KLRA | Kailera Therapeutics, Inc. | USD 16.23 | ▲ 2.4% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 12:48 UTC. This page is informational and not investment advice.